2018 International Congress » Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Date: Sunday, October 7, 2018

Time: 1:45pm-3:15pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:45pm-3:15pm: [18F]FP-CIT and [18F]FDG PET findings in MSA patients with cognitive impairment

KB. Lee, YJ. Park, C. Lee (Seoul, Republic of Korea)

1:45pm-3:15pm: 18F-FDG PET brain in Parkinsonism

F. Amod (Durban, South Africa)

1:45pm-3:15pm: 91 years old woman with Sjogren’s syndrome and Parkinsonism

M. Augusto, PV. Perin (Atibaia, Brazil)

1:45pm-3:15pm: A case of levodopa responsive rapid onset dystonia-parkinsonism

Y. Fernandez, S. Frucht (New York, NY, USA)

1:45pm-3:15pm: A Case of Parkinsonism due to the Hypoxic-Ischemic Lesions of the Striatum

H. Kaleagasi, N. Oksuz, O. Dogu (Mersin, Turkey)

1:45pm-3:15pm: A longitudinal study of brain quantitative MRI analysis before and after diagnosis of progressive supranuclear palsy

K. Seo, T. Yamamoto, H. Kawasaki, A. Miyake, T. Hukuoka, Y. Nakazato, T. Takahasi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)

1:45pm-3:15pm: A panel of CSF and plasma biomarkers reveals novel biological insights into atypical parkinsonian syndromes

E. Jabbari, J. Woodside, N. Magdalinou, A. Lees, H. Zetterberg, H. (London, United Kingdom)

1:45pm-3:15pm: A Young Man with Multiple System Atrophy: A Case Report

DR. Carneiro, M. Sousa, C. Januário, A. Morgadinho (Coimbra, Portugal)

1:45pm-3:15pm: Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)

A. Shoeibi, I. Litvan, J. Juncos, Y. Bordelon, D. Riley, S. Reich, D. Shprecher, D. Hall, C. Marras, B. Kluger, N. Olfati, J. Jankovic (Mashhad, Islamic Republic of Iran)

1:45pm-3:15pm: Affective impairment and emotional tone of early Richardson’s syndrome and Progressive Supranuclear Palsy with predominant parkinsonism: The role of Alexithymia and Anhedonia

C. Pellicano, F. Assogna, L. Cravello, C. Savini, M. Pierantozzi, A. Stefani, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)

1:45pm-3:15pm: Amyotrophic Lateral Sclerosis-Progressive Supranuclear Palsy Phenotype with Negative C9ORF72 Mutation

S.C. Low, A.H. Tan, M. Ellis, K.J. Goh, S.Y. Lim, A. Ahmad-Annuar, N. Shahrizaila, M. Kennerson (Kuala Lumpur, Malaysia)

1:45pm-3:15pm: An atutopsy case of argyrophilic grain disease, clinically presenting with Parkinson dementia

R. Sengoku, D. Kaneda, M. Kameyama, A. Tokumaru, K. Ishii, K. Kanemaru, Y. Saito, S. Murayama (Tokyo, Japan)

1:45pm-3:15pm: Analysis of Tau Burden and Distribution on the Spectrum of PSP Subtypes

J. Sanchez-Ruiz Gordoa, P. Clavero, M. Zelaya, C. López-Molina, A. Galbete, V. Coca, M. Mendioroz, E. Erro (Pamplona, Spain)

1:45pm-3:15pm: Apolipoprotein E and multiple system atrophy

K. Ogaki, Y. Martens, M. Heckman, S. Koga, L. Labbé, O. Lorenzo-Betancor, A. Wernick, R. Walton, A. Soto, E. Vargas, H. Nielsen, S. Fujioka, T. Kanekiyo, R. Uitti, J. van Gerpen, W. Cheshire, Z. Wszolek, P. Low, W. Singer, N. Hattori, D. Dickson, G. Bu, O. Ross (Tokyo, Japan)

1:45pm-3:15pm: ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy

N. Mendonca, R. Bateman, A. Boxer, J. Braunstein, D. Claassen, D. Holtzman, D. Kerwin, B. Rendenbach-Mueller, H. Soares, D. Wang, G. Höglinger (Ludwigshafen, , Germany)

1:45pm-3:15pm: Assessment of CSF biomarkers clinical value in Progressive Supranuclear Palsy

T. Schirinzi, G. Sancesario, G. Di Lazzaro, N. Mercuri, S. Bernardini, A. Lang, A. Pisani (Rome, Italy)

1:45pm-3:15pm: Association of impaired melatonin secretion with sleep disturbance in multiple system atrophy

T. Nakamura, M. Ueda, M. Suzuki, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)

1:45pm-3:15pm: Atypical Dopamine Responsive Parkinsonism in HIV Seroconversion

N. Siddi Ganie, I. Siddi Ganie, N. Soni (Durban, South Africa)

1:45pm-3:15pm: Atypical Response to Apomorphine in a Patient with Multiple System Atrophy

S. Ozben, F. Genc, F. Tuter Yilmaz, A. Erdal, N. Atis (Antalya, Turkey)

1:45pm-3:15pm: Background pathology of ‘corticobasal degeneration (CBD) mimics’ -Japanese validation study of CBD (J-VAC study)

T. Shimohata, I. Aiba, M. Yoshida, Y. Toyoshima, S. Murayama, T. Uchihara, T. Arai, Y. Saito, H. Takigawa, K. Hasegawa, T. Ikeuchi, M. Hasegawa, T. Komori, K. Wakabarashi, A. Tokumaru, K. Sakurai, K. J-VAC study (Gifu, Japan)

1:45pm-3:15pm: Burden among Patients with Progressive Supranuclear Palsy

T. Xie, X. Ye, L. Kandukuri, Y. Bao (Chicago, IL, USA)

1:45pm-3:15pm: Burden of progressive supranuclear palsy: A systematic literature review

S. Chen, I. Jakab, T. Zelei, L. Szilberhorn, R. Bendes, B. Elezbawy, Z. Kaló, M. Mann, M. Potashman, J. Pitter (Cambridge, MA, USA)

1:45pm-3:15pm: Cerebellar signs in progressive supranuclear palsy

D. Crosiers, A. Sieben, J. Baets, J.J. Martin, P. Cras (Edegem, Belgium)

1:45pm-3:15pm: Cerebrospinal fluid levels of cytokines in multiple system atrophy: A cross-sectional study of the atalan msa registry (CMSAR)

Y. Compta, S. Dias, M. Pulido-Salgado, D. Giraldo, A. Pérez-Soriano, M. Fernández, A. Cámara, P. Bravo, E. Muñoz, J. Saura, MJ. Marti (Barcelona, Spain)

1:45pm-3:15pm: Characterizing the spectrum of Non-motor Symptoms in Progressive Supranuclear Palsy

C. S P, V. Holla, S. Prasad, A. Stezin, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

1:45pm-3:15pm: Clinical features and natural history of pathologically-confirmed corticobasal degeneration: A Japanese validation study of CBD (J-VAC study)

I. Aiba, T. Shimohata, S. Murayama, K. Hasegawa, Y. Iwasaki, O. Yokota, H. Fujimura, M. Sakai, T. Yokota, I. Yabe, H. Takigawa, K. Sugaya, K. Mori, M. Ito, C. Ishida, M. Kobayashi, Y. Hashizume, T. Ikeuchi, M. Hasegawa, M. Yoshida, T. Komori, K. Wakabayashi, Y. Saito, A. Tokumaru, K. Sakurai, K. Nakashima (Nagoya, Japan)

1:45pm-3:15pm: Clinical spectrum of vascular Parkinsonism: A hospital-based study in south India

J. Kuragala, J. Murthy, N. Chaudhary, s. Sharma, S. Jaiswal, Y. Reddy (Anantapur, India)

1:45pm-3:15pm: Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

R. Ojha, K. Oli (Kathmandu, Nepal)

1:45pm-3:15pm: Comparative study of non-motor symptoms in patients with progressive supranuclear palsy and age, gender, duration of illness matched patients with Parkinson’s disease

V. Holla, C. SP, A. Lenka, A. Stezin, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

1:45pm-3:15pm: Comparative study of the cognitive and behavioral disturbances between progressive supranuclear palsy phenotypes

A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, I. Illán, I. Aracil, J. Pérez-Pérez, B. Pascual, H. Bejr-Kasem, J. Marin, F. Sampedro, M. Botí, C. Izquierdo, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

1:45pm-3:15pm: Corticobasal Syndrome: A Single Center Case Series

M. Siddiqui, C. Goas (Winston Salem, NC, USA)

1:45pm-3:15pm: Deep brain stimulation in a patient with Spinocerebellar ataxia type 2 presenting as Parkinson’s disease: A case report

J. Im, Y. Lee, S. Paek, B. Jeon (Seoul, Republic of Korea)

1:45pm-3:15pm: Diffusion magnetic resonance imaging for predicting the severity of Progressive supranuclear palsy

X.A. Zhao, S.H. Lin, C.C. Tsai, Y.M. Wu, W.Y. Lin, Y.H. Weng, L.S. Lu, Y.L. Chen, J.J. Wang (Taoyuan City, Taiwan)

1:45pm-3:15pm: Disease progression and survival of multiple system atrophy: A prospective French cohort study

A. Foubert-Samier, A. Pavy-Letraon, F. Guillet, C. Helmer, M. LeGoff, F. Tison, F. Rascol, C. Proust-Lima, W. Meissner (Bordeaux, France)

1:45pm-3:15pm: Effects of mannitol treatment in a mice model of multiple system atrophy (MSA)

N. Lev, Y. Barhum (Kfar Saba, Israel)

1:45pm-3:15pm: Effects of multi-session repetitive transcranial magnetic stimulation on performance of motor control and dynamics of spontaneous brain activity in multiple system atrophy

Z. Liu, H.Z. Ma, X.M. Wang, Z. Wang, Y.Q. Wang, J.H. Zhou, T. Feng (Beijing, China)

1:45pm-3:15pm: Evolution of diagnostic certainty and PSP-predominance types in 187 pathologically confirmed PSP patients

M. Grimm, G. Respondek, I. Piot, T. Arzberger, Y. Compta, E. Englund, L. Ferguson, E. Gelpi, A. Giese, S. Roeber, D. Irwin, W. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, C. Troakes, G. Höglinger (Munich, Germany)

1:45pm-3:15pm: Expanding the NINDS Parkinson’s Disease Biomarkers Program – Utilizing a Major Biomarker Resource to Address Atypical Parkinsonisms and Related Conditions

C. Lungu, K. Arce, D. Babcock, K. David, BA. Sieber, C. Swanson-Fischer, M. Sutherland (Rockville, MD, USA)

1:45pm-3:15pm: Immunological causes of atypical parkinsonism

M. Cesarini, J. Etcheverry, G. Da Prat, G. Rojas, N. Gonzalez Rojas, E. Gatto (La Plata, Argentina)

1:45pm-3:15pm: Influence of Wearing Empty Backpack on Gait and Balance in Patients with Degenerative Parkinsonian syndrome

S. Lee, D. Heo, J. Park (Bucheon, Republic of Korea)

1:45pm-3:15pm: Is safinamide useful for atypical Parkinsonian syndromes?

M. Machío Castelló, M. Oses Lara, C. Feliz Feliz, J. del Val, P. García Ruiz (Madrid, Spain)

1:45pm-3:15pm: Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications?

N. Sawal, P. Bansal, R. Gupta (Chandigarh, India)

1:45pm-3:15pm: Midbrain Diameter Measurements on High-Resolution Computer Tomography Scans to aid diagnosis of Progressive Supranuclear Palsy

S. Potluri, C. Gan, C. Thomas, B. Mohamed, S. Schwarz (Cardiff, United Kingdom)

1:45pm-3:15pm: Midbrain/pons area ratio and clinical features predict the prognosis of PSP

S. Cui, S. Chen (Shanghai, People’s Republic of China)

1:45pm-3:15pm: Motor and cognitive deficits in a mouse model of tauopathy with tau isoforms imbalance: Potential therapeutic strategies

ME. Avale, SL. Espindola, A. Damianich, M. Sartor, J. Ferrario (Buenos Aires, Argentina)

1:45pm-3:15pm: Movement disorders after stroke in the third Moroccan level hospital, Marrakech

A. Chahidi, M. Chraa, N. Kissani (Marrakech, Morocco)

1:45pm-3:15pm: MRI volumetrics in parkinsonian syndromes

K. Ma, A. Chan, L. Shi, J. Abrigo, T. Cheung, C. Lau, V. Mok (Hong Kong, Hong Kong)

1:45pm-3:15pm: MSA Preliminary Panamerican Report

M. Cesarini, E. Gatto, J. Etcheverry, G. Da Prat, N. Gonzalez Rojas, H. Teive, M. Rodriguez, J. Ziliani, M. Miranda, P. Chana, F. Cardoso, A. Cardozo, C. Uribe Roca, I. Amorin, L. Abaroa, c. Cosentino, Y. Nuñez, A. Lescano, E. Dieguez, A. Alleva, I. Litvan, G. Wenning (La Plata, Argentina)

1:45pm-3:15pm: Nilotinib for treating MSA: A preclinical proof of concept study

P. Guerin, M. Lopez-Cuina, E. Bezard, W. Meissner, P-O. (Bordeaux, France)

1:45pm-3:15pm: Non-motor symptoms in patients from the Catalonian Multiple System Atrophy Registry (CMSAR)

D.M. Giraldo, A. Pérez Soriano, J. Rios Guillermo, E. Muñoz, Y. Compta, J. Pagonabarraga, F. Valldeoriola, J. Hernández-Vara, S. Jauma Classen, V. Puente, C. Pont, N. Caballol, E. Tolosa, A. Bayes, J. Campdelacreu, O. Fabregues, A. Avila, M. Calopa, C. Gaig, N. Fabregat, P. Pastor, M. Aguilar, M. Pujol, L. Planellas, A. Camara, M.J. Marti (Barcelona, Spain)

1:45pm-3:15pm: Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

1:45pm-3:15pm: Olfactory testing in Parkinson plus syndromes

O. Abdukarimov, F. Akhmedova (Tashkent, Uzbekistan)

1:45pm-3:15pm: Palliative Virtual Home Visits for Atypical Parkinsonian Disorders (PVH-Park Study)

M. Afshari, A. Butala, J. Guenther, A. Pantelyat, N. Galifianakis (San Francisco, CA, USA)

1:45pm-3:15pm: Patient Perspective in Multiple System Atrophy

A. Mahajan, Z. Mari (Detroit, MI, USA)

1:45pm-3:15pm: PBT434 prevents the accumulation of glial cell inclusions and insoluble alpha-synuclein in a mouse model of Multiple System Atrophy

D. Finkelstein, P. Adlard, N. Stefanova, D. Stamler (Parkville, Vic, Australia)

1:45pm-3:15pm: Peripheral immune activation was associated with multiple system atrophy

B. Cao, XP. Chen, WH. Feng, QQ. Wei, LY. Zhang, HF. Shang (Chengdu, China)

1:45pm-3:15pm: Postural deformities in Chinese patients with multiple system atrophy

L. Zhang, B. Cao, Y. Zou, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shanng (Chengdu, China)

1:45pm-3:15pm: Prevalence of REM sleep behavior disorder and sleep-disordered breathing in multiple system atrophy: A meta-analysis

SL. Wu, CS. Chuang (Changhua, Taiwan)

1:45pm-3:15pm: Probable MSA presenting initially with urinary retention

S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

1:45pm-3:15pm: Progressive Supranuclear Palsy and Eye of the Tiger Sign

O. Dogu, H. Genç, N. Öksüz (Mersin, Turkey)

1:45pm-3:15pm: PROMESA: A randomised, double-blind, placebo-controlled trial to evaluate the progression rate of MSA under EGCG supplementation as anti-aggregation-approach

J. Levin, S. Maass, M. Schuberth, A. Giese, W. Oertel, W. Poewe, C. Trenkwalder, G. Wenning, U. Mansmann, M. Suedmeyer, K. Eggert, B. Mollenhauer, A. Lipp, M. Loehle, J. Classen, A. Muenchau, J. Kassubeck, G. Ebersbach, D. Berg, S. Egert, C. Eberhardt, F. Paul, K. Boetzel, B. Ertl-Wagner, H. Huppertz, I. Ricard, G. Hoeglinger (Munich, Germany)

1:45pm-3:15pm: Pupillary autonomic dysfunction and oculomotor characteristics of multiple system atrophy

K.W. Park, EJ. Lee, N.R. Choi, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

1:45pm-3:15pm: Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy

H. Wang, YW. Zhang, J. Yuan, D. Xu, H. You, ML. Li, F. Feng (Beijing, China)

1:45pm-3:15pm: Quantitative mobility metrics from a body-fixed sensor predict incident parkinsonism in older adults

R. von Coelln, R. Dawe, J. Shulman, L. Yu, S. Leurgans, J. Hausdorff, L. Shulman, D. Bennett, A. Buchman (Baltimore, MD, USA)

1:45pm-3:15pm: Rapamycin for treating MSA: A preclinical proof of concept study

M. Lopez-Cuina, P. Guerin, E. Bezard, W. Meissner, P-O. Fernagut (Bordeaux, France)

1:45pm-3:15pm: Referral and diagnostic time intervals from symptom onset to death in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Parkinson’s disease (PD)

D. Swallow, C. Counsell (Aberdeen, United Kingdom)

1:45pm-3:15pm: Reversible Extrapyramidal features as unusual presentation of central pontine myelinolysis: A case report

S. El-Jaafary, A. Sabbah, S. Ahmed (Cairo, Egypt)

1:45pm-3:15pm: Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study

J. Massa, L. Chahine (Pittsburgh, PA, USA)

1:45pm-3:15pm: Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome

T. Modi, M. Goyal, J. Kaur, B. Medhi (Chandigarh, India)

1:45pm-3:15pm: Serum cholesterol level is associated with risk of MSA

YC. Lu, MC. Kuo, RM. Wu (Taipei, Taiwan)

1:45pm-3:15pm: Serum fractalkine levels in Parkinson’s disease: Evidence for neuroinflammation

G. Nagesh Babu, M. Gupta, V. Paliwal (Lucknow, India)

1:45pm-3:15pm: Serum insulin-like growth factor-1 levels in parkinsonism or dementia disorders

K. Suzuki, S. Suzuki, Y. Ishii, T. Matsubara, H. Fujita, Y. Watanabe, M. Okamura, T. Kadowaki, H. Sakuramoto, K. Hirata (Tochigi, Japan)

1:45pm-3:15pm: Spatial correlation and segregation of multimodal MRI abnormalities in multiple system atrophy

J.H. Lee, M.J. Lee, T.H. Kim (Yangsan-si, Gyeongsangnam-do, Republic of Korea)

1:45pm-3:15pm: Striatal FP-CIT SPECT findings for progressive supranuclear palsy subtypes

M. Yogo, M. Morita, M. Suzuki (Tokyo, Japan)

1:45pm-3:15pm: The Catalonian Multiple System Atrophy Registry (CMSAR): The motor features and their impact on disability status in MSA patients

A. Perez-Soriano, DM. Giraldo, J. Rios-Guillermo, E. Muñoz, Y. Compta, MJ. Marti, On-behalf-of-Catalonian-MSA-Registry (Barcelona, Spain)

1:45pm-3:15pm: The characteristic of gait in progressive progressive supranuclear palsy

Y. Takamatsu, N. Matsuda, I. Aiba (Kyoto, Japan)

1:45pm-3:15pm: The clinical spectrum of motor stereotypies in progressive supranuclear palsy: An early, frequent and underestimated symptom

J. Pagonabarraga, A. Horta-Barba, I. Illan, I. Aracil, H. Bejr-Kasem, J. Pérez-Pérez, J. Marín-Lahoz, B. Pascual-Sedano, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

1:45pm-3:15pm: The impact of APOε4 polymorphisms and mutations in the GBA gene on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, T. Gurevich, A. Orr-Urtreger, N. Gilad, N. Bregman (Tel Aviv, Israel)

1:45pm-3:15pm: The role of deep brain stimulation targeting GPi in patients with multiple system atrophy

P. Hedera, D. Claassen, D. Isaacs (Nashville, TN, USA)

1:45pm-3:15pm: The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy

P. Huang, H.Y. Zhou, Y.Y. Tan, S.D. Chen (Shanghai, China)

1:45pm-3:15pm: The Timed Up & Go test (time) is inversely associated with fall frequency in progressive supranuclear palsy

N. Matsuda, Y. Takamatsu, I. Aiba (Nagoya, Japan)

1:45pm-3:15pm: Toxin-induced Parkinsonism: A report of two patients

Z. Aldaajani (Dhahran, Saudi Arabia)

1:45pm-3:15pm: Unusual prolonged survival in multiple system atrophy: A case report

DM. Giraldo, A. Garrido, C. Simonet, J. Saavedra, Y. Compta, M. Marti, E. Tolosa, F. Valldeoriola (Barcelona, Spain)

1:45pm-3:15pm: Usefulness of combined examination using Frontal Assessment Battery (FAB) and Single Photon Emission Computer Tomography in the differentiation of 4 repeats (4R) tauopathic atypical parkinsonism

P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)

1:45pm-3:15pm: Utility of Acute Levodopa Challenge Test In Early Parkinsonism

M. Acharya, A. Biswas, G. Ganguly, S. Das (Kolkata, India)

1:45pm-3:15pm: Vascular parkinsonism: Clinical features and comparison with Parkinson’s disease

C. Simonet, A. Garrido, F. Valldeoriola, MJ. Martí, Y. Compta (Barcelona, Spain)

1:45pm-3:15pm: What activities increase the risk of falling in atypical parkinsonian syndromes? A comparative study with Parkinson’s disease

P. Panyakaew, N. Kantachadvanich, S. Chaiwong, R. Bhidayasiri (Bangkok, Thailand)

« View all sessions from the 2018 International Congress.